| Literature DB >> 30386280 |
Andrew Switzer1, Warren Caldwell1, Chelsea da Estrela1, Erin T Barker1, Jean-Philippe Gouin1.
Abstract
Respiratory sinus arrhythmia (RSA) is a biomarker of cardiac vagal tone that has been linked to social functioning. Recent studies suggest that RSA moderates the impact of interpersonal processes on psychosocial adjustment. The goal of this study was to assess whether RSA would moderate the association between dyadic coping (DC) and depressive symptoms. Eighty cohabiting couples raising preschool children completed the Dyadic Coping Inventory, the Center for Epidemiological Study-Depression scale and had their RSA assessed during a laboratory session. Couples completed follow-up assessments of depressive symptoms 6 and 12 months later. Data were analyzed using an Actor-Partner Interdependence Model. Results indicated that RSA moderated the actor effect of negative DC on depression in men, such that men with lower RSA had a stronger association between their own ratings of negative DC within the couple relationship and their own depressive symptoms, compared to their counterparts with higher RSA. RSA also moderated the partner effect of delegated DC on depressive symptoms. Among men with higher RSA, there was a significant negative association between their partner's ratings of delegated DC within the couple relationship and the men's depressive symptoms, whereas partner-rated delegated DC was unrelated to depressive symptoms among men with lower RSA. These results suggest that men with higher RSA may possess social skills and abilities that attenuate the association between stressful marital interactions and negative mood.Entities:
Keywords: depression; dyadic coping; heart rate variability; respiratory sinus arrhythmia; social support; stress
Year: 2018 PMID: 30386280 PMCID: PMC6198049 DOI: 10.3389/fpsyg.2018.01959
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Spearman Rho’s correlations among the study variables.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| (1) Actor Depression | – | -0.39** | -0.31** | -0.37** | 0.54** | -0.43** | -0.21 | -0.34** | 0.43** | -0.02 |
| (2) Actor Supportive DC | -0.31** | – | 0.66** | 0.80** | -0.61** | 0.54** | 0.43** | 0.53** | -0.48** | 0.12 |
| (3) Actor Delegated DC | -0.22** | 0.58** | – | 0.57** | -0.46** | 0.41** | 0.34** | 0.35** | -0.22 | 0.06 |
| (4) Actor Common DC | -0.23* | 0.84** | 0.50** | – | -0.50** | 0.54** | 0.44** | 0.62** | -0.33** | 0.07 |
| (5) Actor Negative DC | 0.31** | -0.68** | -0.38** | -0.62** | – | -0.37** | -0.28* | -0.33** | 0.44 | -0.001 |
| (6) Partner Supportive DC | -0.25* | 0.54** | 0.43** | 0.53** | -0.48** | – | 0.58** | 0.84** | -0.68** | 0.15 |
| (7) Partner Delegated DC | -0.21 | 0.41** | 0.34** | 0.35** | -0.22 | 0.66** | – | 0.50** | -0.38** | 0.30** |
| (8) Partner Common DC | -0.30** | 0.54** | 0.44** | 0.62** | -0.34** | 0.80** | 0.57** | – | -0.62 | 0.04 |
| (9) Partner Negative DC | 0.17 | -0.37** | -0.28* | -0.33** | 0.44** | -0.61** | -0.47** | -0.51** | – | -0.09 |
| (10) Actor RSA | -0.08 | 0.04 | 0.08 | -0.08 | 0.005 | -0.09 | -0.02 | -0.18 | 0.05 | – |
| 17.96 (11.67) | 36.91 (7.06) | 14.04 (3.19) | 23.72 (5.91) | 16.98 (5.83) | 36.00 (7.31) | 13.58 (2.80) | 23.41 (5.67) | 15.91 (5.99) | 6.53 (0.81) | |
| 15.18 (8.84) | 36.00 (7.31) | 13.58 (2.80) | 23.41 (5.67) | 15.91 (5.99) | 36.91 (7.06) | 14.04 (3.19) | 23.72 (5.91) | 16.98 (5.83) | 6.08 (0.99) |
Actor and partner effects of DC on depression and moderation effects of RSA for men.
| 95% CI | ||||
|---|---|---|---|---|
| Actor DC | -007 (0.004) | -1.96 | 0.05τ | [-0.01,0.0001] |
| Partner DC | -0.009 (0.004) | -2.05 | 0.04∗ | [-0.02,-0.0002] |
| Daily Stress | 0.01 (0.007) | 1.94 | 0.06τ | [-0.003,0.03] |
| RSA | 0.07 (0.13) | 1.42 | 0.16 | [-0.10,0.60] |
| Actor DC × RSA | 0.001 (0.004) | 0.44 | 0.66 | [-0.007,0.01] |
| Partner DC × RSA | -0.003 (0.004) | -1.28 | 0.20 | [-0.01,0.003] |
| Daily Stress × RSA | -0.008 (0.007) | -1.14 | 0.26 | [-0.02,0.006] |
| Actor DC | -0.03 (0.01) | -2.85 | 0.006∗ | [-0.05,-0.01] |
| Partner DC | -0.005 (0.009) | -0.56 | 0.57 | [-0.02,0.02] |
| Daily Stress | 0.01 (0.007) | 1.76 | 0.08τ | [-0.002,0.03] |
| RSA | 0.38 (0.17) | 2.16 | 0.03∗ | [0.03,0.72] |
| Actor DC × RSA | -0.0003 (0.01) | -0.03 | 0.97 | [-0.01,0.02] |
| Partner DC × RSA | -0.02 (0.009) | -2.10 | 0.04∗ | [-0.04,-0.001] |
| Daily Stress × RSA | -0.007 (0.007) | -0.91 | 0.37 | [-0.02,0.008] |
| Actor DC | -0.006 (0.007) | -0.89 | 0.38 | [-0.02,0.008] |
| Partner DC | -0.009 (0.008) | -1.22 | 0.23 | [-0.02,0.006] |
| Daily Stress | 0.01 (0.007) | 1.83 | 0.07 τ | [-0.001,0.03] |
| RSA | 0.24 (0.17) | 1.44 | 0.15 | [-0.09,0.58] |
| Actor DC × RSA | 0.0001 (0.009) | 0.006 | 0.99 | [-0.02,0.02] |
| Partner DC × RSA | -0.007 (0.007) | -0.97 | 0.34 | [-0.02,0.01] |
| Daily Stress × RSA | -0.01 (0.008) | -1.26 | 0.21 | [-0.02,0.006] |
| Actor DC | 0.01 (0.003) | 3.66 | <0.001** | [0.006,0.02] |
| Partner DC | 0.01 (0.004) | 2.34 | 0.02∗ | [0.001,0.02] |
| Daily Stress | 0.01 (0.006) | 2.27 | 0.03∗ | [0.001,0.03] |
| RSA | 0.18 (0.10) | 1.78 | 0.08τ | [-0.02,0.38] |
| Actor DC × RSA | -0.01 (0.004) | -2.65 | 0.01∗ | [-0.02,-0.003] |
| Partner DC × RSA | 0.002 (0.004) | 0.57 | 0.57 | [-0.006,0.01] |
| Daily Stress × RSA | -0.002 (0.006) | -0.25 | 0.80 | [-0.01,0.01] |
Actor and partner effects of DC on depression and moderation effects of RSA for women.
| 95% CI | ||||
|---|---|---|---|---|
| Actor DC | -0.003 (0.005) | -0.64 | 0.53 | [-0.01,0.006] |
| Partner DC | -0.004 (0.004) | -1.08 | 0.28 | [-0.01,0.004] |
| Daily Stress | 0.01 (0.007) | 1.90 | 0.06τ | [-0.001,0.03] |
| RSA | 0.23 (0.26) | -0.89 | 0.37 | [-0.28,0.75] |
| Actor DC × RSA | -0.004 (0.005) | -0.79 | 0.43 | [-0.01,0.006] |
| Partner DC × RSA | 0.003 (0.005) | 0.67 | 0.51 | [-0.006,0.01] |
| Daily Stress × RSA | -0.02 (0.009) | 1.90 | 0.06τ | [-0.03,0.0008] |
| Actor DC | 0.004 (0.01) | -0.48 | 0.64 | [-0.01,0.02] |
| Partner DC | -0.02 (0.01) | -1.94 | 0.06τ | [-0.04,0.001] |
| Daily Stress | 0.01 (0.007) | 1.86 | 0.07τ | [-0.001,0.03] |
| RSA | 0.27 (0.23) | -0.16 | 0.25 | [-0.20,0.75] |
| Actor DC × RSA | -0.003 (0.01) | 0.34 | 0.73 | [-0.02,0.02] |
| Partner DC × RSA | -0.001 (0.01) | -0.10 | 0.92 | [-0.02,0.02] |
| Daily Stress × RSA | -0.02 (0.008) | 1.90 | 0.04∗ | [-0.03,-0.0004] |
| Actor DC | -0.005 (0.008) | -0.63 | 0.53 | [-0.02,0.01] |
| Partner DC | -0.006 (0.009) | -0.71 | 0.48 | [-0.02,0.01] |
| Daily Stress | 0.01 (0.008) | 1.91 | 0.06 τ | [-0.001,0.03] |
| RSA | 0.26 (0.23) | 1.10 | 0.28 | [-0.21,0.73] |
| Actor DC × RSA | -0.009 (0.008) | -1.16 | 0.25 | [-0.02,0.006] |
| Partner DC × RSA | 0.007 (0.009) | -0.71 | 0.48 | [-0.01,0.02] |
| Daily Stress × RSA | -0.02 (0.008) | -2.04 | 0.04∗ | [-0.04,-0.0004] |
| Actor DC | 0.01 (0.006) | 1.84 | 0.07 τ | [-0.001,0.02] |
| Partner DC | 0.001 (0.005) | 0.26 | 0.79 | [-0.009,0.01] |
| Daily Stress | 0.01 (0.007) | 1.84 | 0.07 τ | [-0.001,0.03] |
| RSA | 0.06 (0.15) | 0.43 | 0.66 | [-0.23,0.36] |
| Actor DC × RSA | 0.0006 (0.007) | 0.09 | 0.92 | [-0.01,0.01] |
| Partner DC x RSA | 0.005 (0.006) | 0.71 | 0.48 | [-0.008,0.02] |
| Daily Stress X RSA | 0.01 (0.008) | -1.46 | 0.15 | [-0.02,0.004] |